Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 8, 2011, Pages 1903-1911

  Camilla, Roberta ^a   Suzuki, Hitoshi ^b,c   Daprà, Valentina ^a   Loiacono, Elisa ^a   Peruzzi, Licia ^a   Amore, Alessandro ^a   Ghiggeri, Gian Marco ^d   Mazzucco, Gianna ^e   Scolari, Francesco ^f   Gharavi, Ali G ^g   Appel, Gerald B ^g   Troyanov, Stéphan ^h   Novak, Jan ^b   Julian, Bruce A ^b   Coppo, Rosanna ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f Montichiari Hospital   (Italy)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; AGGLUTININ; ALBUMIN; FREE SULFHYDRYL GROUPS ON ALBUMIN; GALACTOSE; GALACTOSE DEFICIENT IMMUNOGLOBULIN A1; GLYCAN DERIVATIVE; IMMUNOGLOBULIN A1; PARAPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HELIX ASPERSA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALACTOSE; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN A; ITALY; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; SERUM ALBUMIN; TIME FACTORS; UNITED STATES; UP-REGULATION; YOUNG ADULT;

EID: 80051575524     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11571210     Document Type: Article

References (39)

1. Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J: Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press Res 31: 29-37, 2008
2. Coppo R, Feehally J, Glassock RJ: IgA nephropathy at two score and one. Kidney Int 77: 181-186, 2010
3. Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, Monteiro RC: Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15: 622-634, 2004
4. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R: Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12: 1862-1871, 2001
5. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513, 2005
6. Gómez-Guerrero C, González E, Hernando P, Ruiz-Ortega M, Egido J: Interaction of mesangial cells with IgA and IgG immune complexes: A possible mechanism of glomerular injury in IgA nephropathy. Contrib Nephrol 104: 127-137, 1993
7. Gómez-Guerrero C, López-Franco O, Suzuki Y, Sanjuán G, Hernández-Vargas P, Blanco J, Egido J: Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB. Kidney Int 62: 2022-2034, 2002
8. Chen HC, Guh JY, Chang JM, Lai YH: Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells. Nephron 88: 211-217, 2001
9. Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K: Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10: 822-832, 1999
10. Chen JX, Zhou JF, Shen HC: Oxidative stress and damage induced by abnormal free radical reactions and IgA nephropathy. J Zhejiang Univ Sci B 6: 61-68, 2005
11. Vas T, Wagner Z, Jenei V, Varga Z, Kovács T, Wittmann I, Schinzel R, Balla G, Balla J, Heidland A, Nagy J: Oxidative stress and non-enzymatic glycation in IgA nephropathy. Clin Nephrol 64: 343-351, 2005
12. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noël LH, Guérin AP, London GM, Jungers P: Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markers. Kidney Int 66: 1606-1612, 2004
13. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA: Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19: 1008-1014, 2008
14. Coppo R, Amore A, Chiesa M, Lombardo F, Cirina P, Andrulli S, Passerini P, Conti G, Peruzzi L, Giraudi R, Messina M, Segoloni G, Ponticelli C: Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation. Clin Transplant 21: 728-737, 2007
15. Waldherr R, Rambousek M, Duncker WD, Ritz E: Frequency of mesangial IgA deposits in non-selected autopsy series. Nephrol Dial Transplant 4: 943-946, 1989
16. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294, 2003
17. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1668-1677, 2009
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
19. Work DF, Schwartz GJ: Estimating and measuring glomerular filtration rate in children. Curr Opin Nephrol Hypertens 17: 320-325, 2008
20. Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H, Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 77: 921-927, 2010
21. Reich HN, Troyanov S, Scholey JW, Cattran DC: Toronto Glomerulonephritis Registry: Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18: 3177-3183, 2007
22. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J: IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118: 629-639, 2008
23. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J: Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71: 134-138, 2007
24. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, London GM: Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 45: 39-47, 2005
25. Himmelfarb J, McMonagle E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60: 358-363, 2001
26. Bruschi M, Grilli S, Candiano G, Fabbroni S, Della Ciana L, Petretto A, Santucci L, Urbani A, Gusmano R, Scolari F, Ghiggeri GM: New iodo-acetamido cyanines for labeling cysteine thiol residues. A strategy for evaluating plasma proteins and their oxido-redox status. Proteomics 9: 460-469, 2009
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
28. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998
29. Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V: Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689: 91-102, 2004
30. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X: Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signalling pathway. Antioxid Redox Signal 10: 1699-1712, 2008
31. Wei XF, Zhou QG, Hou FF, Liu BW, Liang M: Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 296: F427-F437, 2009
32. Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP, Tian JW: Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPHdependent mechanisms. Kidney Int 76: 1148-1160, 2009
33. Liu Y: Advanced oxidation protein products: A causative link between oxidative stress and podocyte depletion. Kidney Int 76: 1125-1127, 2009
34. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M, Nakayama M, Hosoya T, Era S: Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin. Kidney Int 66: 1988-1993, 2004
35. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, Otagiri M: Oxidation and carboxy methyl lysinemodification of albumin: Possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 28: 973-980, 2005
36. Coppo R, Camilla R, Alfarano A, Balegno S, Mancuso D, Peruzzi L, Amore A, Dal Canton A, Sepe V, Tovo P: Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int 75: 536-541, 2009
37. Cuzzocrea S: Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 12: 3551-3570, 2006
38. Yatabe J, Sanada H, Yatabe MS, Hashimoto S, Yoneda M, Felder RA, Jose PA, Watanabe T: Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol 296: F1052-F1060, 2009
39. Shah SV, Baliga R, Rajapurkar M, Fonseca VA: Oxidants in chronic kidney disease. J Am Soc Nephrol 18: 16-28, 2007